- Vouliez-vous dire
- geen therapy
Résultats de la recherche - 5 results
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.
replication-defective viral vectors commonly used in gene therapy or vaccination. To our knowledge, this article presents the most extensive and up-to-date review of shedding data reported with OV employed in clinics. ...
Biosafety of viral vectors commonly used in gene therapy and vaccination.
Publication Type: Peer reviewed scientific article Authors: Philippe Herman Source: Curr Gene Ther, Volume 13, Issue 6, p.383-4 (2013) Keywords: Genetic Therapy Genetic Vectors Hazardous Substances ...
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
strain, which has been developed as a vaccine against smallpox, is since the nineties widely tested in clinical trials as recombinant vector for vaccination or gene therapy applications. Although MVA is ...
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.
Clinical Trials as Topic Gene Transfer Techniques Genetic Therapy Genetic Vectors Humans Mammals Neoplasms Poxviridae Infections Practice Guidelines as Topic Vaccination vaccinia virus Viral Vaccines ...
State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.
transfer vehicles, as used for both research and gene therapy applications, because of their stable integration in non-dividing and dividing cells and long-term transgene expression. Along with our ...